Caribou Biosciences CRBU
NASDAQ CRBU
$1.22 -0.05 (-3.94%)
At close: Oct 1, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Other Non-Current Liabilities (2020 - 2022)

Updated

Caribou Biosciences' Other Non-Current Liabilities came in at $9,000 for Q1 2022, down 99.6% from the prior quarter.

Analysis

Caribou Biosciences (CRBU) Other Non-Current Liabilities (2020 - 2022) Analysis & Trends

At the end of FY2021, Caribou Biosciences' Other Non-Current Liabilities was $2.1 million, up 126.7% from FY2020.

  • Going back by year, Other Non-Current Liabilities was $925,000 in FY2020.
  • Business Quant data shows CRBU's Other Non-Current Liabilities at $2.1 million (Q4 2021), $1.83 million (Q3 2021) and $1.57 million (Q2 2021) in the three quarters before Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Caribou Biosciences 134.61 Mn -381.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 9,000.00
Dec 31, 2021 2.10 Mn
Sep 30, 2021 1.83 Mn
Jun 30, 2021 1.57 Mn
Dec 31, 2020 925,000.00
API Access

Caribou Biosciences Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CRBU&period=max&api_key=YOUR_API_KEY